Gemcitabine hydrochloride

White crystalline powder, odorless

Cytosine≤0.1%

α-anomer≤0.1%

Other individual impurity≤0.2%

Residue on ignition≤0.1%

Heavy metals≤10ppm

Assay:97.5~101.5%

Gemcitabine hydrochloride is a synthetic novel difluoro nucleoside drug that is anti-metabolic and antineoplastic. 

Suitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.